These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 373460)

  • 1. Regulation of the immune response to tumor antigen.
    Greene MI; Perry LL; Benacerraf B
    Am J Pathol; 1979 Apr; 95(1):159-69. PubMed ID: 373460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide.
    Naito K; Pellis NR; Kahan BD
    Cancer Res; 1988 Jan; 48(1):101-8. PubMed ID: 3257158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulation by various nitrosoureas and its effect on the survival of the murine host bearing a syngeneic tumor.
    Nagarkatti M; Toney DM; Nagarkatti PS
    Cancer Res; 1989 Dec; 49(23):6587-92. PubMed ID: 2573418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
    Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
    J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoregulation in cancer-bearing hosts. Down-regulation of gene expression and cytotoxic function in CD8+ T cells.
    Loeffler CM; Smyth MJ; Longo DL; Kopp WC; Harvey LK; Tribble HR; Tase JE; Urba WJ; Leonard AS; Young HA
    J Immunol; 1992 Aug; 149(3):949-56. PubMed ID: 1353099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the immune response to tumor antigen. IV. Tumor antigen-specific suppressor factor(s) bear I-J determinants and induce suppressor T cells in vivo.
    Perry LL; Benacerraf B; Greene MI
    J Immunol; 1978 Dec; 121(6):2144-7. PubMed ID: 82578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential antigen presentation in tumor immunity.
    Schatten S; Drebin JA; Granstein RD; Greene MI
    Fed Proc; 1984 Jun; 43(9):2460-4. PubMed ID: 6327399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclophosphamide-induced immunologically mediated regression of a cyclophosphamide-resistant murine tumor: a consequence of eliminating precursor L3T4+ suppressor T-cells.
    Awwad M; North RJ
    Cancer Res; 1989 Apr; 49(7):1649-54. PubMed ID: 2522344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ; Wheelock EF
    Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts.
    Fujimoto S; Greene MI; Sehon AH
    J Immunol; 1976 Mar; 116(3):791-9. PubMed ID: 1082894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A syngeneic metastatic tumor model in mice: the natural immune response of the host and its manipulation.
    Treves AJ; Cohen IR; Feldman M
    Isr J Med Sci; 1976; 12(4-5):369-84. PubMed ID: 1084880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host reactivity against clonable tumor cells and the total tumor cell population, studied in a syngeneic murine lymphoma system.
    Gjedde SB
    Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):101-8. PubMed ID: 6349250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine therapy of established tumors in the absence of autoimmunity.
    Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J
    Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-specific chemoimmunotherapy of murine fibrosarcoma using tumor-specific transplantation antigen, cyclophosphamide, and interleukin-2.
    Naito K; Nomi S; Komichi H; Ueda Y; Yamagishi H; Oka T; Pellis NR; Kahan BD
    Cancer Detect Prev; 1992; 16(5-6):321-7. PubMed ID: 1361881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirements for T cell recognition and elimination of retrovirally-transformed cells.
    Greenberg P; Klarnet J; Kern D; Okuno K; Riddell S; Cheever M
    Princess Takamatsu Symp; 1988; 19():287-301. PubMed ID: 2479634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell-deprived mice lack functional expression of certain T suppressor cell subsets.
    Flood PM; Janeway CA; Gershon RK
    J Mol Cell Immunol; 1984; 1(3):167-76. PubMed ID: 6242856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The augmentation of tumor-specific immunity by T-T cell interaction].
    Fujiwara H; Takai Y; Fukuzawa M; Yoshioka T; Izumi Y; Mizushima Y; Qian J; Ogata M; Kosugi A; Nakajima H
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):734-40. PubMed ID: 3157349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced TNP-reactive helper T cell activity and its utilization in the induction of amplified tumor immunity that results in tumor regression.
    Fujiwara H; Moriyama Y; Suda T; Tsuchida T; Shearer GM; Hamaoka T
    J Immunol; 1984 Mar; 132(3):1571-7. PubMed ID: 6198397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential for specific cancer therapy with immune T lymphocytes.
    Cheever MA; Greenberg PD; Fefer A
    J Biol Response Mod; 1984; 3(2):113-27. PubMed ID: 6233396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.